Dermatology Nurses' Association Annual Convention 2026

This session will provide a comprehensive overview of the management of psoriasis using an interactive, and fun case-based format. We will review the pathogenesis and clinical presentation of the many variants of psoriasis. We will identify and explain the immune-based targets that provide therapeutic targets, focusing on the newest psoriasis treatments. Finally, we will discuss patient education to enhance understanding and adherence to therapy and improved quality of life.

This presentation provides an up-to-date overview of lichen planus, highlighting advances in understanding its pathogenesis and clinical variants. Dr. Vesely will discuss current and emerging treatment strategies—from topical and systemic immunomodulators to novel targeted therapies—emphasizing a practical, evidence-based approach to managing this challenging inflammatory skin disease.

Allergic contact dermatitis is an inflammatory skin response that affects about 1 in 5 people and is diagnosed using patch testing (PT). Traditional PT requires three in-person clinical appointments spread over 5 days using standardized allergen panels that are not tailored to a patient’s unique risk profile. The allergens are typically applied to the patient’s back, which necessitates that the test vehicle be removed and read by trained medical staff. This process creates long waits, specialist shortages, and substantial financial and logistical burdens for patients. Our personalized, AI-assisted approach reimagines PT by transitioning it from provider-led to patient-centered testing. Patches are placed on the volar forearm, allowing patients to easily access the test site and document reactions using a smartphone app. This solution expands access and reduces test burden while supporting providers through evidence-based allergen recommendations, AI-assisted interpretation, and automated documentation that together guide diagnosis.

Our experience with Autohemotherapy (AHT) and Plasma-Rich Fibrin (PRF) as an alternative therapeutic approach to treatment of Psoriasis. AHT involves injecting a small amount of a patient's own blood, drawn from a vein, into gluteal muscle; thereby, triggering systemic immunomodulatory effects. PRF intralesional (IL) or subcutaneous (SQ) was used to augment AHT in case of extensive psoriatic plaques coverage.

Our experience with Autohemotherapy (AHT) and Plasma-Rich Fibrin (PRF) as an alternative therapeutic approach to treatment of Psoriasis. AHT involves injecting a small amount of a patient's own blood, drawn from a vein, into gluteal muscle; thereby, triggering systemic immunomodulatory effects. PRF intralesional (IL) or subcutaneous (SQ) was used to augment AHT in case of extensive psoriatic plaques coverage.

Have you ever been stumped by a clinical scenario when caring for a pediatric dermatology patient? Then this session is for you. The presenters will review perplexing cases from their careers as well as confusing cases submitted by conference attendees.

Have you ever been stumped by a clinical scenario when caring for a pediatric dermatology patient? Then this session is for you. The presenters will review perplexing cases from their careers as well as confusing cases submitted by conference attendees.